US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 51.085
  • +0.005+0.01%
Trading Dec 13 14:06 ET
1.95BMarket Cap-13.62P/E (TTM)

About Tarsus Pharmaceuticals Company

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Company Profile

SymbolTARS
Company NameTarsus Pharmaceuticals
Listing DateOct 16, 2020
Issue Price16.00
Founded2017
CEODr. Bobak Azamian, M.D.,PhD
MarketNASDAQ
Employees244
Fiscal Year Ends12-31
Address15440 Laguna Canyon Road,Suite 160
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-409-9820

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bobak Azamian, M.D.,PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 3.13M
  • Dr. Elizabeth Yeu-Lin, M.D.
  • Chief Medical Officer
  • 180.21K
  • Dianne C. Whitfield
  • Chief Human Resources Officer
  • --
  • Aziz Mottiwala, M.B.A.
  • Chief Commercial Officer
  • --
  • Jeffrey S. Farrow
  • Chief Financial Officer and Chief Strategy Officer
  • 3.99M
  • Dr. Seshadri Neervannan, PhD
  • Chief Operating Officer
  • 1.74M
  • Wendy L. Yarno, M.B.A.
  • Lead Independent Director
  • 265.83K
  • Dr. Bhaskar Chaudhuri,PhD
  • Independent Director
  • 178.58K
  • Rosemary A. Crane, M.B.A.
  • Independent Director
  • 183.71K
  • Dr. William J. Link,PhD
  • Independent Director
  • 183.33K
  • Scott Morrison
  • Independent Director
  • 186.46K
  • Dr. Andrew Goldberg, M.D.
  • Independent Director
  • 171.71K
  • Dr. Bryan Wahl, J.D.,M.D.
  • General Counsel and Secretary
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data